Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (Beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 12, Issue 3, 2001, Pages 219-225

  Yoo, Byong Chul ^a   Cairns, Nigel ^b   Fountoulakis, Michael ^c   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Alzheimer's disease; Brain; Down syndrome; Synaptosomal proteins; Synaptotagmin I

Indexed keywords

BETA SYNAPTOSOMAL BRAIN PROTEIN; BRAIN PROTEIN; GAMMA SYNAPTOSOMAL BRAIN PROTEIN; N ETHYLMALEIMIDE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CELL LOSS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; NERVE CELL; NERVE CONDUCTION; NEUROPATHOLOGY; PARIETAL LOBE; PRIORITY JOURNAL; SYNAPSE; SYNAPTOGENESIS; TEMPORAL LOBE; THALAMUS; TWO DIMENSIONAL ELECTROPHORESIS;

ADULT; ALZHEIMER DISEASE; BRAIN; CALCIUM-BINDING PROTEINS; DOWN SYNDROME; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; SYNAPTOSOMES; SYNAPTOTAGMIN I; SYNAPTOTAGMINS;

EID: 0035103479     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051261     Document Type: Article

References (43)

1. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast
2. The N-ethylmaleimide-sensitive fusion protein (NSF) is preferentially expressed in the nervous system
3. A possible docking and fusion particle for synaptic transmission
4. Soluble NSF-attachment proteins
5. A multisubunit particle implicated in membrane fusion
6. 2+ channel is functionally coupled to the exocytotic machinery
7. Interactions between proteins implicated in exocytosis and voltage-gated calcium channels
8. Calcium-dependent oligomerization of synaptotagmins I and II. Synaptotagmins I and II are localized on the same synaptic vesicle and heterodimerize in the presence of calcium
9. The subcellular localizations of atypical synaptotagmins III and VI. Synaptotagmin III is enriched in synapses and synaptic plasma membranes but not in synaptic vesicles
10. Differential distributions of novel synaptotagmins: Comparison to synapsins
11. Cellular localization of synaptotagmin I, II, and III mRNAs in the central nervous system and pituitary and adrenal glands of the rat
12. 2+ sensor for transmitter release at a central synapse
13. Synaptotagmin IV is an immediate early gene induced by depolarization in PC12 cells and in brain
14. Synaptotagmin I is a high affinity receptor for clathrin AP-2: Implications for membrane recycling
15. Federated two-dimensional electrophoresis databases: A simple means of publishing two-dimensional electrophoresis data
16. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
17. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
18. Decrease of heart protein kinase C, PKA, and cyclin-dependent kinase precedes death in perinatal asphyxia of the rat
19. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
20. Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis
21. Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery
22. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease
23. Regulation of synaptotagmin I phosphorlyation by multiple protein kinase
24. Phosphorylation of the cytoplasmic domain of Alzheimer's β-amyloid precursor protein at Ser655 by a novel protein kinase
25. Protein phosphorylation and the regulation of synaptic membrane traffic
26. Structural and functional conservation of synaptotagmin (p65) in drosophila and humans
27. Developmental regulation of synaptotagmin I, II, III, and IV mRNAs in the rat CNS
28. The metabolic and molecular basis of inherited disease
29. A statistical note of cerebellar and brain stem weight in mongolism
30. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months
31. The anterior commissure in Down's syndrome
32. Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study
33. Dendritic atrophy in children with Down's syndrome
34. Growth and development of the brain in Down syndrome
35. Dendrites, dementia and the Down syndrome
36. Neuronal density and synaptogenesis in the postnatal stage of brain maturation in Down syndrome
37. Hypothalamic abnormalities in Down syndrome
38. Synaptic development in the human fetus: A morphometric analysis of normal and Down's syndrome neocortex
39. Voltage-dependent interaction between the muscarinic ACh receptor and proteins of the exocytic machinery
40. Differential synaptic loss in the cortex in Alzheimer's disease: A study using archival material
41. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease
42. Neurochemical dissection of synaptic pathology in Alzheimer's disease
43. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: A new biochemical marker for synaptic pathology in Alzheimer disease?